Time to Remove 'Cancer' Label From Low-Risk Prostate Tumors?

Dropping the 'C word' would curtail anxiety and reduce overtreatment, some experts have argued, but not everyone embraces the idea.

Related Keywords

Johns Hopkins University , Maryland , United States , National Institutes Of Health , California , Sweden , Pennsylvania , Baltimore , San Francisco , Scott Eggener , Sophiris Bio , Joe Gallo , Jonathan Epstein , Peter Carroll , Mark Lichty , University Of California , Us Preventive Services Task , University Of Chicago , Surveillance Patients International , National Institutes , Medscape Medical , Services Task Force , Status Quo , Active Surveillance Patients International , Francis Medical , Profound Medical , Candel Therapeutics , Janssen Biotech , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Cancer , Alignant Neoplasia , Arcinoma , Metastasis , Oncology Practice , Ncology Practice Management , Biopsy , Tumor , Medical Life , Hysician Lifestyle , Edical Lifestyle , Esident Lifestyle , Edical Student Lifestyle , Urse Lifestyle , Practice Management , Prostatic , Erectile Dysfunction , Impotence ,